BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17009941)

  • 1. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies.
    Tapsall J
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):619-28. PubMed ID: 17009941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance in Neisseria gonorrhoeae.
    Tapsall JW
    Clin Infect Dis; 2005 Aug; 41 Suppl 4():S263-8. PubMed ID: 16032562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins.
    Tapsall JW
    Curr Opin Infect Dis; 2009 Feb; 22(1):87-91. PubMed ID: 19532086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.
    Tapsall JW; Ndowa F; Lewis DA; Unemo M
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):821-34. PubMed ID: 19735224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.
    Tapsall JW; Limnios EA; Murphy D;
    J Antimicrob Chemother; 2008 Jan; 61(1):150-5. PubMed ID: 17986492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002.
    Commun Dis Intell Q Rep; 2003; 27(4):488-91. PubMed ID: 15508502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
    Tapsall JW
    Sex Transm Infect; 2009 Aug; 85(4):256-8. PubMed ID: 19261600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gonococcus fights back: is this time a knock out?
    Lewis DA
    Sex Transm Infect; 2010 Nov; 86(6):415-21. PubMed ID: 20656721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden.
    Golparian D; Hellmark B; Fredlund H; Unemo M
    Sex Transm Infect; 2010 Nov; 86(6):454-60. PubMed ID: 20940159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004.
    Stathi M; Flemetakis A; Miriagou V; Avgerinou H; Kyriakis KP; Maniatis AN; Tzelepi E
    J Antimicrob Chemother; 2006 Apr; 57(4):775-9. PubMed ID: 16492719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial resistance pattern of Neisseria gonorrhoeae isolates from peripheral health centres and STD clinic attendees of a tertiary care centre in India.
    Bala M; Ray K; Gupta SM
    Int J STD AIDS; 2008 Jun; 19(6):378-80. PubMed ID: 18595874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2005.
    WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme
    Commun Dis Intell Q Rep; 2006; 30(4):430-3. PubMed ID: 17330383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting.
    Whiley DM; Goire N; Lahra MM; Donovan B; Limnios AE; Nissen MD; Sloots TP
    J Antimicrob Chemother; 2012 Sep; 67(9):2059-61. PubMed ID: 22604449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
    Matsumoto T
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of gonorrhea: what effect will antibiotic resistance have in the future?
    Sparling PF
    Sex Transm Dis; 1979; 6(2 Suppl):120-5. PubMed ID: 115098
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
    Vázquez JA; Martín E; Galarza P; Giménez MJ; Aguilar L; Coronel P
    Int J Antimicrob Agents; 2007 Apr; 29(4):473-4. PubMed ID: 17276040
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospects of untreatable gonorrhea and ways forward.
    Whiley DM; Lahra MM; Unemo M
    Future Microbiol; 2015; 10(3):313-6. PubMed ID: 25812453
    [No Abstract]   [Full Text] [Related]  

  • 20. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.